These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17585156)

  • 21. Opportunities and challenges for the development of pharmacological therapies for obesity treatment.
    Cawthorne MA
    Obes Rev; 2007 Mar; 8 Suppl 1():131-6. PubMed ID: 17316316
    [No Abstract]   [Full Text] [Related]  

  • 22. Bush declines to support drug companies' line on AIDS profits.
    Dickson D
    Nature; 2001 Mar; 410(6824):3. PubMed ID: 11241998
    [No Abstract]   [Full Text] [Related]  

  • 23. [Application for exemption concerning Xenical was refused without explanation].
    Homann P
    Lakartidningen; 2001 Nov; 98(45):5040. PubMed ID: 11816911
    [No Abstract]   [Full Text] [Related]  

  • 24. The search for quick and easy measures to combat obesity.
    Health Care Food Nutr Focus; 2004 Aug; 21(8):8-9. PubMed ID: 15473191
    [No Abstract]   [Full Text] [Related]  

  • 25. Companies throw their weight behind new antiobesity drugs.
    Cahoon L
    Nat Med; 2010 Feb; 16(2):136. PubMed ID: 20134442
    [No Abstract]   [Full Text] [Related]  

  • 26. Reefer sanity.
    Wadman M
    Fortune; 2003 Nov; 148(11):58, 62. PubMed ID: 14666557
    [No Abstract]   [Full Text] [Related]  

  • 27. Pill profits.
    Barnett M
    US News World Rep; 2003 Dec; 135(22):40-1. PubMed ID: 14712783
    [No Abstract]   [Full Text] [Related]  

  • 28. The trouble with fat-burner pills.
    Smith IK
    Time; 2001 Aug; 158(8):66. PubMed ID: 11534484
    [No Abstract]   [Full Text] [Related]  

  • 29. Determining when obesity is a disease.
    Dausch J
    J Am Diet Assoc; 2001 Mar; 101(3):293. PubMed ID: 11269605
    [No Abstract]   [Full Text] [Related]  

  • 30. An update on the pharmacological treatment of obesity.
    Schnee DM; Zaiken K; McCloskey WW
    Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Novel anti-obesity drugs].
    Tripp B; Ludvik B
    Acta Med Austriaca; 2004; 31(4):133-8. PubMed ID: 15732249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How small changes led to big profits for insulin manufacturers.
    Cohen D; Carter P
    BMJ; 2010 Dec; 341():c7139. PubMed ID: 21159773
    [No Abstract]   [Full Text] [Related]  

  • 33. AIDS drugs & the pharmaceutical industry: a need for reform.
    Griffin MT
    Am J Law Med; 1991; 17(4):363-410. PubMed ID: 1812767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-obesity action of Salix matsudana leaves (Part 1). Anti-obesity action by polyphenols of Salix matsudana in high fat-diet treated rodent animals.
    Han LK; Sumiyoshi M; Zhang J; Liu MX; Zhang XF; Zheng YN; Okuda H; Kimura Y
    Phytother Res; 2003 Dec; 17(10):1188-94. PubMed ID: 14669254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs bill to rein in profits.
    Gershon D
    Nature; 1994 Mar; 368(6470):381. PubMed ID: 8133874
    [No Abstract]   [Full Text] [Related]  

  • 36. What is the long-term efficacy and tolerability of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity in primary care?
    Leiser JP; Gunning K
    J Fam Pract; 2000 Jun; 49(6):572-3. PubMed ID: 10923560
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug reimbursement and GPs' prescribing decisions: a randomized case-vignette study about the pharmacotherapy of obesity associated with type 2 diabetes: how GPs react to drug reimbursement.
    Verger P; Rolland S; Paraponaris A; Bouvenot J; Ventelou B
    Fundam Clin Pharmacol; 2010 Aug; 24(4):509-16. PubMed ID: 19840120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-obesity agents do not seem to have any beneficial effects. Health centers prescribe preparations haphazardly, according to a medical records study].
    Forslund T; Wettermark B; Raaschou P; Hjemdahl P; Krakau I
    Lakartidningen; 2010 Mar 31-Apr 13; 107(13-14):910-3. PubMed ID: 20432865
    [No Abstract]   [Full Text] [Related]  

  • 39. Perspectives. Wanna lower health costs? Don't look to drug profits.
    Med Health; 2001 Apr; 55(15):suppl 2 p.. PubMed ID: 11338362
    [No Abstract]   [Full Text] [Related]  

  • 40. Withdrawal of sibutramine. Editorial is judgment in advance of the facts.
    Finer N;
    BMJ; 2010 Mar; 340():c1346. PubMed ID: 20219799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.